Lv61
1740 积分 2023-10-15 加入
TMA secondary to SLE: rituximab improves overall but not renal survival
2小时前
已完结
Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome
13天前
已完结
Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease
13天前
已关闭
Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease
13天前
已关闭
Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease
13天前
已关闭
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
17天前
已完结
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT
28天前
已完结
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
28天前
已完结
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies
28天前
已完结
Complement‐mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study
1个月前
已完结
皖公网安备34019202002308
